Status:

COMPLETED

Omegaven® in the Treatment of Parenteral Nutrition (PN) Induced Liver Injury

Lead Sponsor:

Wake Forest University Health Sciences

Conditions:

Total Parenteral Nutrition-induced Cholestasis

Eligibility:

All Genders

4-18 years

Phase:

PHASE2

Brief Summary

The purpose of this study is to determine whether the omega-3 fatty acid emulsion (Omegaven®), when used in place of the conventional soy-based fat emulsion (Intralipid), is effective in treating pare...

Detailed Description

Rationale for Omegaven® Treatment Unlike conventional intravenous fat emulsions, Omegaven® is comprised solely of fish oils containing primarily omega-3 fatty acids. Animal studies have shown that IV...

Eligibility Criteria

Inclusion

  • Children 0-18 years of age
  • Patients will be PN-dependent and expected to continue PN for at least 30 days
  • Patients considered eligible for study participation must have PN-associated liver diseases . Other causes of liver disease (i.e., biliary atresia, galactosemia, alpha-1 antitrypsin deficiency) will be excluded. A liver biopsy is not necessary for treatment
  • Direct bilirubin \> 2.0 mg/dl
  • Signed patient informed consent
  • Signed patient assent where applicable.

Exclusion

  • Pregnancy
  • Other causes of chronic liver disease (cystic fibrosis, biliary atresia, alpha-1 antitrypsin deficiency)
  • Signs of advanced liver disease including cirrhosis on biopsy, varices, ascites
  • The patient is allergic to eggs/shellfish
  • The patient has a severe hemorrhagic disorder
  • The patient is enrolled in any other clinical trial involving an investigational agent (unless approved by the designated physicians on the multidisciplinary team)
  • The parent or guardian or child unwilling to provide consent or assent.

Key Trial Info

Start Date :

July 1 2010

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

July 1 2020

Estimated Enrollment :

11 Patients enrolled

Trial Details

Trial ID

NCT01845116

Start Date

July 1 2010

End Date

July 1 2020

Last Update

November 23 2022

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Levine Children's Hospital at Carolinas HealthCare System

Charlotte, North Carolina, United States, 28232-2861

Omegaven® in the Treatment of Parenteral Nutrition (PN) Induced Liver Injury | DecenTrialz